TAVR in Congenital Heart Disease...Really?
Presenter
Athar M. Qureshi, M.D., FSCAI, FSCAI, Texas Children's Hospital, Bellaire, TX
Athar M. Qureshi, M.D., FSCAI, FSCAI, Texas Children's Hospital, Bellaire, TX
Learning Objectives:
- Assess the use and outcomes of TAVR in congenital heart disease, focusing on its benefits and challenges.